NEUROLOGIE PRO PRAXI / Neurol. praxi. 2023;24(2):140-144 / www.neurologiepropraxi.cz 144 Z POMEZÍ NEUROLOGIE Molekulární a buněčná biologie roztroušené sklerózy LITERATURA 1. Arneth B. Multiple Sclerosis and Smoking. Am J Med. 2020; 133(7):783-788. 2. Ayuso T, Aznar P, Soriano L, et al. Vitamin D receptor gene is epigenetically altered andtranscriptionally up‑regulated in multiple sclerosis. PLoS One. 2017;12(3):e0174726. 3. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23: 781-783. 4. Bjornevik K, Cortese M, Healy B, et al. Longitudinal analysis reveals high prevalence of Epstein‑Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296-301. 5. Burt RK, Balabanov R, Burman J, et al. Effect of nonmyeloablatice hematopoetic tem cell transplantation vs continued disease‑modifying therapy on disease progression in patients with relapsing‑remitting multiple sclerosis: a randomized clinical trial. JAMA. 2019;321(2):165-174. 6. Celarain N, Roig TJ. Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis. Front Genet. 2019;10:1138. 7. Celarain N, Roig TJ. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. J Neuroinflammation. 2020;17(1):21. 8. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;72(9648):1502-17. 9. Deisenhammer, F, Zetterberg H, Fitzner B, Zettl UK. The Cerebrospinal Fluid in Multiple Sclerosis. Front Immunol. 2019;10:726. 10. Gao Y, Han D, Feng J. MicroRNA in multiple sclerosis. Clin Chim Acta. 2021;516:92-99. 11. Garcias M, Casaccia P. Epigenetic mechanism in multiple sclerosis. Rev Esp Escler Mult. 2014;6(29):25-35. 12. Genc B, Bozan HR, Genc S, Genc K. Stem cell therapy for multiple sclerosis. Adv Exp Med Biol. 2019;145-174. 13. Ghasemi N, Ravazi S, Nikzad E. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell‑Based Therapy. Cell J. 2017;19(1):1-10. 14. Hojati Z. Molecular Genetic and Epigenetic Basic of Multiple Sclerosis. Adv Exp Med Biol. 2017;958:65-90. 15. Chan VS. Epigenetics in Multiple clerosis. Adv Exp Med Biol. 2020; 253:309-374. 16. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol (Paris). 2016;172(1):3-13. 17. Lin ST, Huang Y, Zhang L, et al. MicroRNA-23a promotes myelination in the central nervous system. Proc Natl Acad Sci USA. 2013;110(43):17468-73. 18. Murugaiyan G, Beynon V, Mittal A, et al. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2011;187(5):2213-21. 19. Mycko MP, Branzini SE. microRNA and exosome profiling in multiple sclerosis. Mult Scler. 2020;26(5):599-604. 20. Patergnani S, Fossati V, Bonora M, et al. Mitochondria in Multiple Sclerosis: Molecular Mechanisms of Pathogenesis. Int Rev Cell Mol Biol. 2017;328:49-103. 21. Petrou P, Kassis I, Levin N, et al. Beneficial effect of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020; 143(12):3574-3588. 22. Pierrot‑Deseilligny Ch, Souberbielle JC. Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disord. 2017;14:35-45. 23. Riggs AD, Martienssen RA, Russo VEA. Introduction. In Epigenetic mechanisms of gene regulation (ed. Russo VEA, et al.), pp. 1–4. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 24. Scolding NJ, Pasquini M, Reingold SC, Cohen JA. Cell ‑based therapeutic strategies for multiple sclerosis. Brain. 2017;140(11):2776-2796. 25. Sládková V. Diagnostika roztroušené sklerózy, typické klinické příznaky. Med. praxi. 2015;12(5):236-242. 26. Vališ M, Pavelek Z. Základní diagnostika a léčba roztroušené sklerózy. Med. praxi. 2015;12(2):77-82. 27. Weber M, Hellmann I, Stadler MB, et al. Ditribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007;39(4): 457-66. 28. Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114(3):A160-7. MÍSTO KONÁNÍ Hotel Soláň Bzové 339, 756 05 Karolinka Více informací na www.vlns.cz 15. valašsko-lašské neurologické sympozium 3.–4. 11. 2023 Hotel Soláň, Karolinka
RkJQdWJsaXNoZXIy NDA4Mjc=